CELC

112.63

0.27% -0.30

Dopo l'orario di chiusura: 112.63

Celcuity Inc (CELC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$112.93

Aprire:

$109.2

Volume 24 ore:

501.39K

Relative Volume:

0.70

Capitalizzazione di mercato:

$5.44B

Reddito:

Utile/perdita netta:

$-177.04M

Rapporto P/E:

-29.74

EPS:

-3.7867

Flusso di cassa netto:

$-153.53M

1 W Prestazione:

-1.90%

1M Prestazione:

+4.00%

6M Prestazione:

+127.90%

1 anno Prestazione:

+1,103%

Intervallo 1D:

$109.20

$114.65

Intervallo di 1 settimana:

$104.91

$117.91

Portata 52W:

$7.575

$120.31

Celcuity Inc Stock (CELC) Company Profile

Nome

Celcuity Inc

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

763-392-0767

Indirizzo

16305 36TH AVENUE N, MINNEAPOLIS, MN

Dipendente

155

Cinguettio

Prossima data di guadagno

2026-03-25

Ultimi documenti SEC

CELC's Discussions on Twitter

Compare CELC vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CELC Celcuity Inc	112.63	5.44B	0	-177.04M	-153.53M	-3.7867
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Celcuity Inc Stock (CELC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-12	Iniziato	Wells Fargo	Overweight
2025-11-18	Iniziato	Wolfe Research	Outperform
2025-11-17	Downgrade	H.C. Wainwright	Buy → Neutral
2025-09-22	Iniziato	Guggenheim	Buy
2025-07-01	Ripresa	Stifel	Buy
2024-07-22	Iniziato	Leerink Partners	Outperform
2024-02-22	Iniziato	Stifel	Buy
2023-12-08	Iniziato	H.C. Wainwright	Buy
2021-10-08	Iniziato	Canaccord Genuity	Buy
2021-09-07	Iniziato	Jefferies	Buy
2021-07-29	Iniziato	Cowen	Outperform
2021-07-27	Iniziato	Needham	Buy
2021-01-28	Reiterato	H.C. Wainwright	Buy
2020-12-24	Reiterato	H.C. Wainwright	Buy
2020-05-11	Ripresa	Craig Hallum	Buy
2018-11-20	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Celcuity Inc Borsa (CELC) Ultime notizie

Apr 04, 2026

Celcuity outlines potential $2.5B annual peak revenue for gedatolisib amid pivotal clinical milestones and commercial launch preparations - MSN

Apr 02, 2026

Celcuity (CELC) 10K Form and Latest SEC Filings 2026 - MarketBeat

Apr 02, 2026

Apr 01, 2026

CELC PE Ratio & Valuation, Is CELC Overvalued - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Aug Update: Can Celcuity Inc ride the EV waveEarnings Growth Summary & Verified Technical Trade Signals - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Baker Bros. Advisors LP Increases Stake in Celcuity Inc. - GuruFocus

Mar 30, 2026

Aug Big Picture: Is Celcuity Inc stock a smart retirement pickMarket Trend Review & Entry Point Confirmation Signals - baoquankhu1.vn

Mar 30, 2026

Hennion & Walsh Asset Management Inc. Acquires 19,579 Shares of Celcuity, Inc. $CELC - MarketBeat

Mar 30, 2026

Tudor Investment Corp ET AL Invests $1.35 Million in Celcuity, Inc. $CELC - MarketBeat

Mar 30, 2026

HC Wainwright Increases Earnings Estimates for Celcuity - MarketBeat

Mar 30, 2026

Mar 29, 2026

Why Celcuity Stock Popped Today - aol.com

Mar 29, 2026

Assessing Celcuity (CELC) Valuation After FDA Priority Review And Commercial Launch Preparations - simplywall.st

Mar 29, 2026

Mar 28, 2026

Liquidity Mapping Around (CELC) Price Events - Stock Traders Daily

Mar 28, 2026

LifeSci Capital Maintains Celcuity(CELC.US) With Buy Rating, Maintains Target Price $125 - Moomoo

Mar 28, 2026

Celcuity (NASDAQ:CELC) Upgraded to Hold at Wall Street Zen - MarketBeat

Mar 28, 2026

Mar 27, 2026

H.C. Wainwright reiterates Celcuity stock rating at neutral By Investing.com - Investing.com India

Mar 27, 2026

Celcuity Inc. (NASDAQ:CELC) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 27, 2026

H.C. Wainwright reiterates Celcuity stock rating at neutral - Investing.com

Mar 27, 2026

1290 VT Micro Cap Portfolio's Celcuity Inc(CELC) Holding History - GuruFocus

Mar 27, 2026

Mar 26, 2026

Why Celcuity stock popped today - MSN

Mar 26, 2026

Celcuity’s Earnings Call: Big Data, Bigger Ambitions - TipRanks

Mar 26, 2026

Why Celcuity Stock Popped Today - The Motley Fool

Mar 26, 2026

Stifel Raises Price Target for Celcuity (CELC) to $125, Maintains Buy Rating | CELC Stock News - GuruFocus

Mar 26, 2026

Trade Recap: Will Celcuity Inc stock recover after earningsQuarterly Trade Review & Daily Volume Surge Signals - baoquankhu1.vn

Mar 26, 2026

Celcuity Inc. 2025 Annual Report: Clinical-Stage Biotech Advancing Gedatolisib for Breast Cancer Treatment - minichart.com.sg

Mar 26, 2026

Stifel raises Celcuity stock price target to $125 on trial timing By Investing.com - Investing.com India

Mar 26, 2026

Stifel raises Celcuity stock price target to $125 on trial timing - Investing.com India

Mar 26, 2026

Craig-Hallum raises Celcuity stock price target to $141 on NDA progress By Investing.com - za.investing.com

Mar 26, 2026

Craig-Hallum raises Celcuity stock price target to $141 on NDA progress - Investing.com

Mar 26, 2026

Celcuity (NASDAQ:CELC) Price Target Raised to $125.00 - MarketBeat

Mar 26, 2026

Celcuity's (CELC) "Buy" Rating Reiterated at Needham & Company LLC - marketbeat.com

Mar 26, 2026

Celcuity Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 26, 2026

Celcuity 10-K: $0 Revenue, $(3.79) EPS; $177M Net Loss - TradingView

Mar 26, 2026

Celcuity (NASDAQ: CELC) highlights pivotal gedatolisib trials and FDA Priority Review - Stock Titan

Mar 26, 2026